TradingView
Glamych
May 6, 2021 11:16 PM

ZYNE 

NASDAQ:ZYNE240

描述

⋅
Zynerba Pharma Receives FDA Guidance For Phase 3 Trial Of Zygel
Trend AnalysisTechnical Indicators
更多